News & Views | Published:

Precision medicine for autoimmune disease

Nature Biotechnology volume 34, pages 930932 (2016) | Download Citation

An antigen-specific cell therapy for autoimmune disease avoids compromising immunity as a whole.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Science 353, 179–184 (2016).

  2. 2.

    N. Engl. J. Med. 347, 911–920 (2002).

  3. 3.

    Curr. Opin. Pharmacol. 23, 92–97 (2015).

  4. 4.

    et al. J. Invest. Dermatol. 135, 742–749 (2015).

  5. 5.

    & F1000 Res. 5, 1513 (2016).

  6. 6.

    et al. J. Neurosci. 29, 13898–13908 (2009).

  7. 7.

    , & Exp. Cell Res. 325, 2–9 (2014).

  8. 8.

    & Autoimmun. Rev. 12, 1039–1045 (2013).

  9. 9.

    , , , & Acta Obstet. Gynecol. Scand. 95, 98–105 (2016).

  10. 10.

    et al. J. Exp. Med. 184, 2049–2053 (1996).

  11. 11.

    et al. N. Engl. J. Med. 361, 2143–2152 (2009).

Download references

Author information

Affiliations

  1. Lucienne Chatenoud is at the Université Paris Descartes, Sorbonne Paris Cité, Paris, France, and INSERM U1151, CNRS UMR 8253, INEM Hôpital Necker-Enfants Malades, Paris, France.

    • Lucienne Chatenoud

Authors

  1. Search for Lucienne Chatenoud in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Lucienne Chatenoud.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.3670

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing